By Dr. Robert Haugen
Pharmaceutical manufacturing is now undergoing significant transformation. COVID-19 and its pressure on nearly every aspect of human life has put a gigantic emphasis on rapid development of prescriptives, vaccines, and accelerated means for pharmaceutical mass-production.
Newer highly potent active pharmaceutical ingredients (HPAPI) hold great promise for the health of the planet, while posing manufacturing challenges for plant workers and their packaging and validating associates. As we design such facilities, we are likely to produce new equipment and containment strategies that look nothing like what we have today.
Flow Sciences’ role in this evolution must be to develop containment devices that complement the different and unique types of equipment we already know will be present. These changes must allow lightning fast research, valid conclusions, rapid development of production strategies, and increased facility efficiency and worker safety.
The writer will characterize the new production directions in pharmacy and describe flexible equipment to improve pharma efficiency, purity, and production safety in the coming decade.